RET/PTC rearrangement in thyroid tumors

Endocrine Pathology

Volumn 13, Issue 1, 2002, Pages 3-16

  Nikiforov, Yuri E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Chromosomal rearrangement; RET gene; RET PTC; Thyroid; Tumor

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; PROTEIN TYROSINE KINASE; DROSOPHILA PROTEIN; ONCOPROTEIN; PROTEIN RET; RET ONCOGENE PROTEIN, DROSOPHILA;

AGE; GENE REARRANGEMENT; GEOGRAPHIC DISTRIBUTION; HASHIMOTO DISEASE; HUMAN; IN SITU HYBRIDIZATION; NORTH AMERICA; ONCOGENE RET; PRIORITY JOURNAL; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID HYPERPLASIA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; ANIMAL; GENETICS; PAPILLARY CARCINOMA; THYROID TUMOR;

ANIMALS; CARCINOMA, PAPILLARY; DROSOPHILA PROTEINS; GENE REARRANGEMENT; HUMANS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0035986363     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/ep:13:1:03     Document Type: Review

References (86)

1. Activation of a novel human transforming gene, ret, by DNA rearrangement
2. Structure and expression of the ret transforming gene
3. GDNF family neurotrophic factor signaling: Four masters, one servant?
4. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret
5. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease
6. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
7. Molecular characterization of RET/PTC3: A novel rearranged version of the RET protooncogene in a human thyroid papillary carcinoma
8. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas
9. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC
10. The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2
11. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A
12. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5
13. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas
14. Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma
15. A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8)
16. Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET protooncogene in radiation-induced childhood papillary thyroid carcinoma
17. RET/PCM-1: A novel fusion gene in papillary thyroid carcinoma
18. Leucine zipper-mediated dimerization is essential for the PTC1 oncogenic activity
19. The RET proto-oncogene in human cancers
20. Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins
21. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells
22. The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane
23. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas
24. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice
25. The RET/PTC3 oncogene: Metastatic solid-type papillary carcinomas in murine thyroids
26. The TRK and RET tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line
27. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure
28. Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma
29. Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas
30. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype
31. RET rearrangements in papillary thyroid carcinomas and adenomas detected by interphase FISH
32. RET rearrangements in familial papillary thyroid carcinomas
33. Development of a single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma
34. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children
35. Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease
36. Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation
37. Ret oncogene activation in papillary thyroid carcinoma: Prevalence and implication on the histological parameters
38. Immunohistochemical diagnosis of papillary thyroid carcinoma
39. RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes
40. Involvement of RET oncogene in human tumours: Specificity of RET activation to thyroid tumours
41. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method
42. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation
43. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis
44. Ret/PTC-1 activation in Hashimoto thyroiditis
45. RET/PTC rearrangements in thyroid nodules: Studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults
46. Detection of the PTC/retTPC oncogene in human thyroid cancers
47. Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas
48. Oncogene profile of papillary thyroid carcinoma
49. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
50. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: Correlation with clinicopathological features
51. Low rate of ret protooncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia
52. Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia
53. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas
54. Ret rearrangements in Japanese pediatric and adult papillary thyroid cancers
55. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas
56. Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl
57. Gene rearrangements in radiation-induced thyroid carcinogenesis
58. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia
59. The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults
60. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: Biological, phenotypic, and clinical implications
61. Sporadic ret-rearranged papillary carcinoma of the thyroid: A subset of slow growing, less aggressive thyroid neoplasms?
62. Oncogenic rearrangements of the RET protooncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident
63. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident
64. Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus
65. In vitro irradiation is able to cause RET oncogene rearrangement
66. Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis
67. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation
68. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells
69. RET/PTC oncogene activation is an early event in thyroid carcinogenesis
70. Molecular basis of hurthle cell papillary thyroid carcinoma
71. Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: Clinical implications and suggestions for early detection
72. Familial adenomatous polyposis-associated thyroid cancer: A clinical, pathological, and molecular genetics study
73. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: A strong correlation between RET/PTC3 and the solid-follicular variant
74. Solid variant of papillary thyroid carcinoma: Incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior
75. Ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: Implications for metastatic potential?
76. RET/PTC1 and RET/PTC3 rearrangements are associated with different biological behavior of papillary thyroid carcinoma
77. Different significance of ret/PTC(1) and ret/PTC(3) rearrangements in thyroid carcinogenesis: Lesson from two subgroups of patients with papillary thyroid carcinomas showing the highest incidence of ret/PTC activation
78. Thyroid-stimulating hormone promotes growth of thyroid carcinomas in transgenic mice with targeted expression of the ret/PTC1 oncogene
79. Hyalinizing trabecular adenoma of the thyroid gland
80. PLAT paraganglioma-like adenomas of the thyroid
81. RET/PTC activation in hyalinizing trabecular tumors of the thyroid
82. Hyalinizing trabecular tumor of the thyroid: A variant of papillary carcinoma proved by molecular genetics
83. The relationship between Hashimoto's thyroiditis, thyroid neoplasia, and primary hyperparathyroidism
84. Struma lymphomatosa and carcinoma of the thyroid
85. Cancer risks in patients with chronic lymphocytic thyroiditis